She graduated in Genomic Biotechnology from the University of Rome "La Sapienza" and subsequently obtained a Master's in Forensic Genetics from the University of Rome "Tor Vergata." From 2014 to 2017, she was a Postgraduate Internship Fellow at the Medical Genetics Laboratory of the University of Rome "Tor Vergata." In 2020, Federica also obtained a PhD in Medical Biotechnology and Translational Medicine at the Laboratory of Pathological Anatomy of the University of Rome "Tor Vergata" and then the title of specialist in Medical Genetics at the Medical Genetics Laboratory of the University of Rome "Tor Vergata". Since 2021, she has been working as a Post-Doc Fellow at Professor Novelli's Medical Genetics Laboratory, where she conducts research on genetic diseases, particularly Myotonic dystrophy. Her work involves the development of organoids to test various therapeutic approaches, such as indole-3-carbinol, for COVID-19 and in the study of the mechanisms of senescence in health and disease.